![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 19, 2000 8:46:16 PM
We intend to enable the application of human genomics to help
prevent, define and diagnose disease. We will do this by developing
a new high throughput informatics platform by which SNPs and
complex sets of SNPs can be holistically and comprehensively
associated with complex diseases and physical traits.
Our model is to license/partner our platform to generate 21st century
medicines, and enable personalized medical analysis. We will do
this through a combination of license/partnerships, hardware and
software placement and application service provider (ASP) based
models.
Copyright DNAprint genomics © 2000
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM